Role of granulocyte and granulocyte–macrophage colony stimulating factors in the treatment of small-cell lung cancer: a systematic review of the literature with methodological assessment and meta-analysis
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
In order to clarify the role of haematological colony-stimulating factors (CSF) in the treatment of small-cell lung cancer, we performed a systematic review of the randomised trials published on this topic. Since 1991, 12 studies were eligible, including a total of 2107 randomised patients. They were divided into three groups: (1) maintenance of dose-intensity when chemotherapy was given at conventional doses and time intervals (seven trials); (2) accelerated chemotherapy with increased dose-intensity by reducing the delay between chemotherapy cycles (five trials); (3) concentration of chemotherapy on an overall shorter duration time with a lower number of cycles (one trial). Before quantitative aggregation, we performed a methodological assessment using two previously published quality scales (Chalmers and ELCWP). The median quality scores for the pooled 12 trials was 59.9% (range: 42.2-82.0%) for the ELCWP scale and 55.8% (range: 38.0-76.8%) for the Chalmers scale. No statistically significant difference was observed between positive (significant) and negative (non-significant) studies allowing us to perform a meta-analysis. A detrimental effect on response rate was associated with CSF administration in the maintenance group (RR 0.92; 95% confidence interval [CI] 0.87-0.97) without significant effect on survival (HR 1.004; 95% CI, 0.89-1.13). In the accelerated group, no significant impact on response rate (RR 1.02; 95% CI, 0.94-1.09) or survival (HR 0.82; 95% CI, 0.67-1.00…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
(2000) · Queen Mary Research Online (Queen Mary University of London) · Cited by 1,795
Crawford, J., Ozer, H., Stoller, R., Johnson, D., Lyman, G., Tabbara, I., Kris, M., Grous, J., Picozzi, V., Rausch, G., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199107183250305 · Cited by 1,390
A method for assessing the quality of a randomized control trial
Chalmers, T. C., Smith, H., Blackburn, B., Silverman, B., Schroeder, B., Reitman, D., & Ambroz, A. (1981) · Controlled Clinical Trials · doi:10.1016/0197-2456(81)90056-8 · Cited by 1,349
The Medical Review Article: State of the Science
MULROW, C. D. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-3-485 · Cited by 856 · cited 1×
“This approach is only based on the fully published studies and provides an exhaustive and critical analysis of the topic with an adequate methodology based on the criteria of Mulrow [12] and with data aggregation (meta-analysis) when possible.”
MethodTrillet-Lenoir, V., Green, J., Manegold, C., Von Pawel, J., Gatzemeier, U., Lebeau, B., Depierre, A., Johnson, P., Decoster, G., Tomita, D., et al. (1993) · European Journal of Cancer · doi:10.1016/0959-8049(93)90376-q · Cited by 543
Mascaux, C., Paesmans, M., Berghmans, T., Branle, F., Lafitte, J. J., Lemaı̂tre, F., Meert, A. P., Vermylen, P., & Sculier, J. P. (2000) · Lung Cancer · doi:10.1016/s0169-5002(00)00127-6 · Cited by 270
Self-citationThatcher, N., Girling, D. J., Hopwood, P., Sambrook, R. J., Qian, W., Stephens, R. J., & for the Medical Research Council Lung Cancer Working Party (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.2.395 · Cited by 224
Bunn, P. A., Crowley, J., Kelly, K., Hazuka, M. B., Beasley, K., Upchurch, C., Livingston, R., Weiss, G. R., Hicks, W. J., & Gandara, D. R. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.7.1632 · Cited by 190
Steward, W. P., von Pawel, J., Gatzemeier, U., Woll, P. J., Thatcher, N., Koschel, G., Clancy, L., Verweij, J., de Wit, R., Pfeifer, W., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.642 · Cited by 149
Woll, P. J., Hodgetts, J., Lomax, L., Bildet, F., Cour-Chabernaud, V., & Thatcher, N. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.3.652 · Cited by 125
Cited by
Smith, T. J., Khatcheressian, J., Lyman, G. H., Ozer, H., Armitage, J. O., Balducci, L., Bennett, C. L., Cantor, S. B., Crawford, J., Cross, S. J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.4451 · Cited by 1,636
Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials
Pildal, J., Hrobjartsson, A., Jorgensen, K., Hilden, J., Altman, D., & Gotzsche, P. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dym087 · Cited by 472
Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Ganti, A. K. P., Loo, B. W., Bassetti, M., Blakely, C., Chiang, A., D'Amico, T. A., D'Avella, C., Dowlati, A., Downey, R. J., Edelman, M., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.0058 · Cited by 486
Treatment of extensive-stage small cell lung carcinoma: current status and future prospects
Demedts, I. K., Vermaelen, K. Y., & van Meerbeeck, J. P. (2010) · European Respiratory Journal · doi:10.1183/09031936.00105009 · Cited by 216
Sung, L., Nathan, P. C., Alibhai, S. M. H., Tomlinson, G. A., & Beyene, J. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-6-200709180-00010 · Cited by 190
Metadata
- Authors
- Berghmans, T., Paesmans, M., Lafitte, J. J., Mascaux, C., Meert, A. P., & Sculier, J. P.
- Affiliations
- Institut Jules Bordet (BE)
- Centre Hospitalier Universitaire de Lille (FR)
- Corresponding author
- Berghmans, T
- Venue
- Lung Cancer
- Publisher
- Elsevier BV
- Published
- 2002-08
- Volume
- 37
- Issue
- 2
- Pages
- 115-123
- ISSN
- 0169-5002 (ISSN-L)
- OpenAlex
- W1970255471
- Cited by
- 50
- References
- 24
- Citations by year
- 2024: 1 · 2023: 1 · 2022: 1 · 2021: 1 · 2018: 1 · 2017: 1 · 2016: 1 · 2014: 3 · 2013: 2 · 2012: 3
- FWCI
- 0.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Lung Cancer (publishedVersion)
- PubMed (publishedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Lung Cancer Research Studies
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
- Keywords
- small cell lung cancer, granulocyte colony-stimulating factor, GM-CSF, colony-stimulating factors, chemotherapy dose intensity, chemotherapy response rate, survival, hematologic toxicity
- MeSH terms
- Humans, Lung Neoplasms, Randomized Controlled Trials as Topic, Granulocyte-Macrophage Colony-Stimulating Factor, Granulocyte Colony-Stimulating Factor, Treatment Outcome, Carcinoma, Small Cell
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Role of granulocyte and granulocyte–macrophage colony stimulating factors in the treatment of small-cell lung cancer: a systematic review of the literature with methodological assessment and meta-analysis. https://app.cochat.ai/papers/10.1016/s0169-5002(02)00082-x
- The paper
- Berghmans, T., Paesmans, M., Lafitte, J. J., Mascaux, C., Meert, A. P., & Sculier, J. P. (2002). Role of granulocyte and granulocyte–macrophage colony stimulating factors in the treatment of small-cell lung cancer: a systematic review of the literature with methodological assessment and meta-analysis. Lung Cancer. https://doi.org/10.1016/s0169-5002(02)00082-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.